参考文献/References:
[1]Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid,2016,26(10):1343-1421.
[2]Dupuy DE,Monchik JM,Decrea C,et al. Radiofrequency ablation of regional recurrence from welldifferentiated thyroid malignancy. Surgery,2001,130(6):971-977.
[3]Lim HK, Lee JH, Ha EJ, et al. Radiofrequency ablation of benign nonfunctioning thyroid nodules:4year followup results for 111 patients. Eur Radiol,2013,23(4):1044-1049.
[4]王龙琦,陈坚,刘绪舜.微波消融术治疗2例原发性甲状旁腺功能亢进.中国微创外科杂志,2016,16(6):541-543.
[5]Tagami T, Yambe Y, Tanaka T, et al. Shotterm effects of adrenergic antagonists and methimazole in newonset thyrotoxicosis caused by Graves’ disease. Int Med,2012,51(17):2285-2290.
[6]中华医学会内分泌学会《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南——甲状腺功能亢进.中华内分泌杂志,2007,46(10):876-882.
[7]Committee on Pharmaceutical Affairs, Japanese Society for Pediatric Endocrinology, the Pediatric Thyroid Disease Committee, et al. Guidelines for the treatment of childhoodonset Graves’ disease in Japan,2016. Clin Pediatr Endocrinol,2017,26(2):29-62.
[8]Na DG,Lee JH,Jung SL,et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol,2012,13(2):117-125.
[9]葛明华,徐栋.甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗.浙江省专家共识(2015版).中国普通外科杂志,2016,25(7):944.